Scott Tarriff, President and CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 18,360 shares at $66.03 ($1.2M) on 2016-02-01, disclosed to the SEC on 2016-02-02.
Open-market sale of $1.2M EGRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.03 | 5,367 | $354K | 28.4% |
| 2 | $67.46 | 3,600 | $243K | 19.4% |
| 3 | $68.52 | 5,260 | $360K | 28.8% |
| 4 | $69.95 | 2,431 | $170K | 13.6% |
| 5 | $71.84 | 1,702 | $122K | 9.8% |
| Total | $68.08 avg | 18,360 |
| $1.2M |
| 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |